Citations

Citations to this article as recorded by  

• Histological efficacy of anti‐diabetic agents in MASH and the mediating role of weight loss: A network meta‐analysis
  Mainak Banerjee, Rimesh Pal, Sandip Pal
  Diabetes, Obesity and Metabolism.2026; 28(1): 287.     CrossRef
• Glucagon‐like peptide‐1 receptor agonists in pediatric metabolic dysfunction‐associated steatotic liver disease
  Andrea M. Tou, Jennifer Panganiban
  Journal of Pediatric Gastroenterology and Nutrition.2026; 82(1): 146.     CrossRef
• Advances in Incretin‐Based Therapies for MAFLD: Mechanisms and Clinical Evidence
  Wenqi Dong, Haiming Zhang, Shaowei Mu, Shuyi Shi, Junli Zhang, Keshu Xu
  Clinical Pharmacology & Therapeutics.2026; 119(2): 336.     CrossRef
• Safety and Tolerability of Glucagon-Like Peptide-1 Receptor Agonists: A State-of-the-Art Narrative Review
  Setor K. Kunutsor, Samuel Seidu
  Drugs.2026; 86(1): 11.     CrossRef
• Anti-adipogenic effect of cryptotanshinone in 3T3-L1 preadipocytes via binding to glucagon-like peptide 1 receptor and its signaling
  Md․Abdur Rakib, Yong-Sik Kim
  Phytomedicine.2026; 150: 157666.     CrossRef
• Efficacy of liraglutide on metabolic and reproductive outcomes in women with polycystic ovary syndrome: A systematic review and meta‐analysis
  Yu‐Ting Lu, Po‐Han Chang, Hsuan‐Ju Chen, Ya‐Wen Hsueh, Chia‐Wei Chang, Hsi‐Chen Hsu, Tung‐Chuan Yang, Wu‐Chou Lin, Hsun‐Ming Chang
  Diabetes, Obesity and Metabolism.2026;[Epub]     CrossRef
• Comparative effectiveness of Chinese herbal medicine versus liraglutide for weight loss in adults with obesity: A 12-month real-world target trial emulation study
  Yu-Ning Liao, Tsung-Hsien Yang, Yi-Chin Lu, Liang-Wei Tseng, Ching-Wei Yang, Yu-Tung Huang, Hsing-Yu Chen
  Integrative Medicine Research.2026; 15(3): 101291.     CrossRef
• High Cell Density Fermentation Strategy for High-Level Soluble Expression of Glucagon-like Peptide-1 Analogue in Escherichia coli
  Sushmita R. Kumar, Esha Shukla, Gaurav Pandey
  Fermentation.2026; 12(1): 53.     CrossRef
• Improving Lipid Profiles Through Lactobacillus rhamnosus Supplementation in Dyslipidemic Animal Models: A Systematic Review and Meta-Analysis
  Sungmin Chung, Jiill Jeong, Yeonwoo Park, Bogyeong Lee, Sumin Kang, Gwang-woong Go
  Foods.2026; 15(3): 465.     CrossRef
• Semaglutide-Mediated Remodeling of Adipose Tissue in Type 2 Diabetes: Molecular Mechanisms Beyond Glycemic Control
  Tatjana Ábel, Éva Csobod Csajbókné
  International Journal of Molecular Sciences.2026; 27(3): 1186.     CrossRef
• PLEIOTROPIC EFFECTS OF GLP-1 RECEPTOR AGONISTS: A LITERATURE REVIEW
  Wiktoria Marzec, Hanna Maruchniak, Paulina Biedroń, Anna Skrzypek, Maciej Hutkowski, Mikołaj Zbrożek, Zuzanna Chwostek, Bartłomiej Kosiarski, Patrycja Markowicz, Krzysztof Biłyk
  International Journal of Innovative Technologies in Social Science.2026;[Epub]     CrossRef
• Potential Antiarrhythmic Mechanisms of Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs)
  Jianhong Li, Kun Fu, Jiaqian Zhao, Ying Zou, Li Li, Qiuyuan Huang, Limei Long, Xianhong Ou, Ming Lei, Chunxiang Zhang, Xiaoqiu Tan, Tangting Chen
  Drug Design, Development and Therapy.2026; Volume 20: 1.     CrossRef
• Single vs. Dual Agonist Pharmacotherapy for Managing Insufficient Weight Loss and Weight Regain Following Metabolic and Bariatric Surgery: A Comparative Review
  Claudia Reytor-González, Martín Campuzano-Donoso, Gerardo Sarno, Martha Montalvan, Raquel Horowitz, Gianluca Rossetti, Vincenzo Pilone, Luigi Barrea, Giovanna Muscogiuri, Luigi Schiavo, Daniel Simancas-Racines
  Nutrients.2026; 18(4): 553.     CrossRef
• Lifestyle management approaches for obesity
  Matthew J. Landry, Zohaib Bagha
  Journal of Clinical Lipidology.2026; 20(1): 38.     CrossRef
• Oncometabolites and Hypoxia-Regulated Exosomes Shape HIF-Driven Macrophage Programs Across Type 2 Diabetes, Atherosclerosis, and Cancer
  Antonina Nowinka, Gabriela Krystek, Zuzanna Gontarek, Martyna Góralczyk, Antonina Waligórska, Marta Walenciak, Dorota Formanowicz
  International Journal of Molecular Sciences.2026; 27(5): 2291.     CrossRef
• The Effects of SGLT2 Inhibitors on Muscle Health in Older Adults: A Systematic Review and Meta‐Analysis
  Weena Joongpan, Nittaya Boonmuen, Pimthong Sinchai, Sarawut Lapmanee, Natawat Klamsakul, Nutthapoom Pathomthongtaweechai
  Pharmacology Research & Perspectives.2026;[Epub]     CrossRef
• Incretin hormones: Revolutionizing the treatment landscape for kidney and liver diseases in type 2 diabetes and obesity
  Jae Hyun Bae, Young Min Cho
  Journal of Diabetes Investigation.2025; 16(2): 183.     CrossRef
• Lipoprotein(a) in atherosclerotic cardiovascular disease, type 2 diabetes, and liver disease
  Kathryn L. Williams, Maya Augustine, Eru Sujakhu, Justine Magadia, Lindsay Crawford, Aimee Knott, Skyler Hamilton, Uzoma Obiaka
  Progress in Pediatric Cardiology.2025; 76: 101775.     CrossRef
• The protective effects of liraglutide in reducing lipid droplets accumulation and myocardial fibrosis in diabetic cardiomyopathy
  Chien-Yin Kuo, Sing-Hua Tsou, Edy Kornelius, Kuei-Chuan Chan, Kai-Wei Chang, Jung-Chi Li, Chien-Ning Huang, Chih-Li Lin
  Cellular and Molecular Life Sciences.2025;[Epub]     CrossRef
• An oral liraglutide nanomicelle formulation conferring reduced insulin-resistance and long-term hypoglycemic and lipid metabolic benefits
  Laxman Subedi, Arjun Dhwoj Bamjan, Susmita Phuyal, Jung-Hyun Shim, Seung-Sik Cho, Jong Bae Seo, Kwan-Young Chang, Youngro Byun, Seho Kweon, Jin Woo Park
  Journal of Controlled Release.2025; 378: 637.     CrossRef
• Engineering a high‐throughput clone for industrial‐scale production of long‐acting GLP‐1 analogue with retained bio‐efficacy
  Praveen Kumar Reddy J, Murali Tummuru, Kunka Mohanram Ramkumar
  Biotechnology Progress.2025;[Epub]     CrossRef
• Role of molecular hydrogen in obesity treatment: modulation of GLP-1, irisin, and PGC-1α for improved metabolism
  Nikola Todorović, Jovan Kuzmanovic, Dejan Javorac, Sergej M. Ostojic
  Medical Gas Research.2025; 15(3): 442.     CrossRef
• Association between GLP-1 RAs and DPP-4 inhibitors with biliary disorders: pharmacovigilance analysis
  Long He, Jinwei Li, Xiong Cheng, Li Luo, Yilan Huang
  Frontiers in Pharmacology.2025;[Epub]     CrossRef
• Glucagon like peptide-1 receptor agonists as a promising therapeutic option of metabolic dysfunction associated steatotic liver disease and obesity: hitting two targets with one shot
  Eda Kaya, Wing-Kin Syn, Paul Manka
  Current Opinion in Gastroenterology.2025; 41(3): 104.     CrossRef
• 2FA-Platform Generates Dual Fatty Acid-Conjugated GLP-1 Receptor Agonist TE-8105 with Enhanced Diabetes, Obesity, and NASH Efficacy Compared to Semaglutide
  Mun-Teng Wong, Pei-Hsuan Lin, Wei-Chen Lin, Chi-Jiun Peng, Jon D. Wright, Hui-Ju Lee, Hsing-Mao Chu, Carmay Lim, Tse Wen Chang
  Journal of Medicinal Chemistry.2025; 68(6): 6178.     CrossRef
• Perioperative Considerations of Novel Antidiabetic Agents in Heart Failure Patients Undergoing Cardiac Surgery
  Ashley Wang, Savannah Bitzas, Dilsa Perez, Jonathon Schwartz, Saleem Zaidi, Jonathan Oster, Sergio D. Bergese
  Life.2025; 15(3): 427.     CrossRef
• The Role of GLP-1RA Medications in Medical Weight Loss and the Positive Impacts on Lipid Management
  Blair Suter, Allison Rhodes, Allison Bigeh, Timothy Frommeyer, Laxmi S. Mehta
  Current Cardiovascular Risk Reports.2025;[Epub]     CrossRef
• The Role of Short-Chain Fatty Acids in Metabolic Dysfunction-Associated Steatotic Liver Disease and Other Metabolic Diseases
  Eliane Münte, Phillipp Hartmann
  Biomolecules.2025; 15(4): 469.     CrossRef
• Vertical sleeve gastrectomy and semaglutide have distinct effects on skeletal health and heart function in obese male mice
  Caroline de Carvalho Picoli, Sergey Tsibulnikov, Mavy Ho, Victoria DeMambro, Tiange Feng, May Eltahir, Phuong T. Le, Carolyn Chlebek, Clifford J. Rosen, Sergey Ryzhov, Ziru Li
  American Journal of Physiology-Endocrinology and Metabolism.2025; 328(4): E555.     CrossRef
• Pre-fertilization-origin preservation of brown fat-mediated energy expenditure in humans
  Takeshi Yoneshiro, Mami Matsushita, Sayuri Fuse-Hamaoka, Miyuki Kuroiwa, Yuko Kurosawa, Yosuke Yamada, Makoto Arai, Yuchen Wei, Makoto Iida, Kenichi Kuma, Toshimitsu Kameya, Tomoya Harada, Yoshihiro Matsumura, Tsuyoshi Osawa, Yoshiko Aoki, Hisashi Nakamur
  Nature Metabolism.2025; 7(4): 778.     CrossRef
• Comparing Efficacy of Chiglitazar, Pioglitazone, and Semaglutide in Type 2 Diabetes: A Retrospective Study
  Wenxuan Li, Yangang Wang, Chuanfeng Liu, Yongzhuo Yu, Lili Xu, Bingzi Dong
  Diabetes Therapy.2025; 16(5): 993.     CrossRef
• Liraglutide Attenuates FFA-Induced Retinal Pigment Epithelium Dysfunction via AMPK Activation and Lipid Homeostasis Regulation in ARPE-19 Cells
  Sing-Hua Tsou, Kai-Shin Luo, Chien-Ning Huang, Edy Kornelius, I-Ting Cheng, Hui-Chih Hung, Yu-Chien Hung, Chih-Li Lin, Min-Yen Hsu
  International Journal of Molecular Sciences.2025; 26(8): 3704.     CrossRef
• The effect of GLP-1 receptor agonists on cardiac remodeling in heart failure patients with preserved and reduced ejection fraction: a systematic review and meta-analysis
  Hasan Fareed Siddiqui, Saad Ahmed Waqas, Ruqiat Masooma Batool, Hussain Salim, Abdul Mannan Khan Minhas, Syed Farhan Hasni, Amro Alsaid, Anna Sannino, Aasim M. Afzal, Muhammad Shahzeb Khan
  Heart Failure Reviews.2025; 30(5): 991.     CrossRef
• Effects of semaglutide on metabolism and gut microbiota in high-fat diet-induced obese mice
  Luyan Sun, Bingqing Shang, Suyuan Lv, Guolong Liu, Qiu Wu, Yue Geng
  Frontiers in Pharmacology.2025;[Epub]     CrossRef
• Intestinal L-cell mechanoreception regulates hepatic lipid metabolism through GLP-1
  Luyang Gao, Ke Yang, Yawen Zhao, Jinshan Zhang, Shaohua Jiang, Rujiao Zhang, Wenxin He, Yuhang Zhao, Qianqian Ye, Geyang Xu
  Science Advances.2025;[Epub]     CrossRef
• The potential biomarker value of soluble CD36 in the treatment of diabetic kidney disease: evidence from GLP-1 and insulin interventions
  Wenxuan Li, Yangang Wang
  Frontiers in Endocrinology.2025;[Epub]     CrossRef
• Pathogenesis and Therapeutic Perspectives of Tubular Injury in Diabetic Kidney Disease: An Update
  Jiamian Geng, Sijia Ma, Hui Tang, Chun Zhang
  Biomedicines.2025; 13(6): 1424.     CrossRef
• The Role of Peptides in Nutrition: Insights into Metabolic, Musculoskeletal, and Behavioral Health: A Systematic Review
  Syed Khuram Zakir, Bilal Jawed, Jessica Elisabetta Esposito, Rimsha Kanwal, Riccardo Pulcini, Riccardo Martinotti, Edmondo Ceci, Matteo Botteghi, Francesco Gaudio, Elena Toniato, Stefano Martinotti
  International Journal of Molecular Sciences.2025; 26(13): 6043.     CrossRef
• Effect of Semaglutide Add-on to Metformin on Visceral Adiposity Index and Markers of Visceral Adipose Tissue Activity in Type 2 Diabetic Patients
  Abid Shaheer, Mahir Jallo, Shahid Akhtar
  Biomedical and Pharmacology Journal.2025; 18(2): 1565.     CrossRef
• Harnessing adiponectin for sepsis: current knowledge, clinical insights and future therapies
  Stefano Gianoli, Justin Tang, Kirsten C. Odegard, Koichi Yuki, Sophia Koutsogiannaki
  Critical Care.2025;[Epub]     CrossRef
• Effects of antidiabetic medications on the relationship between type 2 diabetes mellitus and cognitive impairment
  Annalisa Cozza, Chiara Chinigò, Elvira Filicetti, Giada Ida Greco, Rosamaria Lappano, Cinzia Marinaro, Lucia Muglia, Luca Soraci, Andrea Corsonello, Fabrizia Lattanzio, Mara Volpentesta
  Ageing Research Reviews.2025; 112: 102834.     CrossRef
• Impact of semaglutide on lipid profiles in overweight and obese non-diabetic adults: A systematic review and meta-analysis of randomized controlled trials
  Sarah Miranda, Jashkumar Choudhari, Nehabahen Chauhan, Mayur S. Parmar
  European Journal of Pharmacology.2025; 1003: 177953.     CrossRef
• Unlocking the potential of GLP-1 receptor agonists in ocular therapeutics: from molecular pathways to clinical impact
  Zhixuan Xie, Zuyi Yang, Dianzhe Tian, Youxin Chen
  Frontiers in Pharmacology.2025;[Epub]     CrossRef
• Glucagon-like peptide-1 receptor agonists improve cholesterol metabolism by inhibiting SREBP-2 via SIRT6-AMPK pathway in HepG2 cells treated with palmitic acid
  Jinmi Lee, Eun-Jung Rhee, Yu-Mi Lim, Seok-Woo Hong, Won-Young Lee
  Cardiovascular Prevention and Pharmacotherapy.2025; 7(3): 61.     CrossRef
• Targeting visceral and ectopic adiposity: Pharmacological and surgical interventions beyond global weight loss
  Mustafa Guldan, Lasin Ozbek, Sama M. Abdel‐Rahman, Arif E. Narin, Helin I. Orak, Hayri Kaan Goren, Baris Afsar, Peter Rossing, Mehmet Kanbay
  Diabetes, Obesity and Metabolism.2025; 27(11): 6116.     CrossRef
• Engineered Lactococcus lactis secreting a glucagon-like peptide-1-inducing protein P9 for amelioration of obesity in mice
  Wenxuan Di, Xiaoyue Bai, Shuangrui Tian, Liang Zhao, Xi Cao, Yanling Hao, Zhengyuan Zhai
  3 Biotech.2025;[Epub]     CrossRef
• Novel therapies – IMID Co-morbidities
  Tsz On Lam, Ho So, Lai-Shan Tam
  Best Practice & Research Clinical Rheumatology.2025; 39(4): 102089.     CrossRef
• Type 2 Diabetes and the Multifaceted Gut-X Axes
  Hezixian Guo, Liyi Pan, Qiuyi Wu, Linhao Wang, Zongjian Huang, Jie Wang, Li Wang, Xiang Fang, Sashuang Dong, Yanhua Zhu, Zhenlin Liao
  Nutrients.2025; 17(16): 2708.     CrossRef
• Sex- and depot-specific adiposity as a driver of cardiovascular ageing
  Pier-Giorgio Masci, Steffen E Petersen
  European Heart Journal.2025; 46(46): 5089.     CrossRef
• A Neural Network Method for Assessing the Nutritional Requirements of a Patient With Type 2 Diabetes
  Sidi M. Mwakalu, Vincent O. Omwenga, Patrick J. Ogao, Pramita Mishra
  Applied Computational Intelligence and Soft Computing.2025;[Epub]     CrossRef
• Global status and trends of proteomics in obesity: a bibliometric analysis and knowledge graph study
  Xiaoying Wu, Yongming Chen, Tong Wu, Qi Pan, Lixin Guo
  Tropical Medicine and Health.2025;[Epub]     CrossRef
• Estimated glucose disposal rate and its dual role in hyperlipidemia risk and mortality: a secondary analysis of retrospective cohort data from U.S. and Chinese
  Shouxin Wei, Sijia Yu, Chuan Qian, Zhengwen Xu, Yindong Jia, Bo Chen
  Lipids in Health and Disease.2025;[Epub]     CrossRef
• GLP-1 and GIP: Magic bullet for musculoskeletal diseases?
  Qihang Fang, Gan Li, Pei Liu, Peng Ding, Youshui Gao
  Journal of Advanced Research.2025;[Epub]     CrossRef
• Comparison of Anti-Obesity Effects of Ginger Extract Alone and Mixed with Long Pepper Extract
  Gunju Song, Hyein Han, Heegu Jin, Jongwon Kim, Hyeongmin Kim, Yi-Seul Seo, Heewon Song, Boo-Yong Lee
  Biomedicines.2025; 13(9): 2077.     CrossRef
• Activation of cyclooxygenase-2 signaling mediates liraglutide-induced adipose lipolytic activity
  Jingyi Li, Hailian Wu, Wenhui Ma, Tao Yuan, Xiaopan Chen, Yong Pan
  European Journal of Pharmacology.2025; 1006: 178133.     CrossRef
• GLP-1RA Reduces Supraspinatus Fatty Infiltration and Promotes Functional Recovery in a Rat Model of Rotator Cuff Repair
  Jong Pil Yoon, Sung-Jin Park, Dong-Hyun Kim, Yoon Seong Choi, Hyun Joo Lee, Jun-Young Kim, Chul-Hyun Cho, Seok Won Chung
  The American Journal of Sports Medicine.2025; 53(12): 2973.     CrossRef
• A synergic GLP-1/Acylethanolamide-based combined therapy for MAFLD: Studies in rat models
  Marialuisa de Ceglia, Rubén Tovar, Miguel Rodríguez-Pozo, Antonio Vargas, Ana Gavito, Juan Suárez, Elena Baixeras, Fernando Rodríguez de Fonseca, Juan Decara
  Biochemical Pharmacology.2025; 242: 117364.     CrossRef
• Role of Glucagon-like Peptide-1 Receptor Agonists (GLP-1RAs) in Patients with Chronic Heart Failure
  Pasqual Llongueras-Espí, Elena García-Romero, Josep Comín-Colet, José González-Costello
  Biomolecules.2025; 15(9): 1342.     CrossRef
• A Combination of Citrus Aurantifolia Fruit Rind and Theobroma cacao Seed Extracts Ameliorates Obesity in High-Fat Diet-Fed Rats via the AMPK Pathway
  SukJin Kim, Sreenath Kundimi, Thirupathi Rao, Sudipta Veeramachaneni, Guru Ramanathan, Yean Kyoung Koo
  Journal of Medicinal Food.2025; 28(11): 1091.     CrossRef
• Outcomes of GLP-1 receptor agonist use following ischemic stroke: a propensity score-matched real-world analysis
  Pranjal Rai, Girish Bathla, Niharika Praveen, Shreya Sri Gopikonda, Huanwen Alvin Chen, Hamza A. Salim, Ahmed Azzam, Muhammed Amir Essibayi, David J. Altschul, Adam A. Dmytriw, Vivek S. Yedavalli, Shahrzad Latifi, Ajay Malhotra, Marco Colasurdo, Dheeraj G
  Journal of Neurology.2025;[Epub]     CrossRef
• GLP-1 Receptor Agonists – Good for Body Weight, Bad for Micronutrient Status?
  Felix Kerlikowsky, Klaus Krämer, Manfred Eggersdorfer, Andreas Hahn
  Current Developments in Nutrition.2025; 9(11): 107587.     CrossRef
• Glucagon-like Peptide-1 Receptor Agonists in Heart Failure: Mechanisms, Evidence and Identifying Optimal Candidates
  Magdy Abdelhamid, Mostafa M Abdrabou, Emanuel Faris, Sameh El Kafas, Mohamed Hosny, Ahmed Hassan
  Cardiac Failure Review.2025;[Epub]     CrossRef
• The perspectives in obesity and type 2 diabetes therapy: the present and future of incretin therapy
  Marina V. Shestakova, Roza O. Bashlykova
  Terapevticheskii arkhiv.2025; 97(10): 823.     CrossRef
• Neurobiological Mechanisms and Therapeutic Potential of Glucagon-like Peptide-1 Receptor Agonists in Binge Eating Disorder: A Narrative Review
  Sujitra Tongta, Titiwat Sungkaworn, Nutthapoom Pathomthongtaweechai
  International Journal of Molecular Sciences.2025; 26(22): 10974.     CrossRef
• Kisspeptin-10 Ameliorates Obesity-Diabetes with Diverse Effects on Ileal Enteroendocrine Cells and Pancreatic Islet Morphology in High-Fat Fed Female Mice
  Ananyaa Sridhar, Dawood Khan, Rithiga Muthukumar, Swetha Sampathkumar, Nigel Irwin, Peter R. Flatt, R. Charlotte Moffett
  Biomolecules.2025; 15(11): 1591.     CrossRef
• The dual burden of obesity: decoding metabolism and female reproductive endocrinology
  Yan Chen, Rongyu Wang, Nannan Zhang, Liangzhi Xu
  Frontiers in Physiology.2025;[Epub]     CrossRef
• High-Density Lipoprotein Dysfunction and Atherosclerotic Cardiovascular Disease: From Quantity to Quality
  Amogh Jyothi Arun, Shigeru Kaneki, Madiha Baig, William H. Frishman, Wilbert S. Aronow
  Cardiology in Review.2025;[Epub]     CrossRef
• Assessing the Midface: Nose and Cheeks
  Kavita Mariwalla, Sabrina Fabi, Daniel Belkin, José R. Montes, Rebecca Fitzgerald, Amelia Hausauer, Wendy Lee, Charles Boyd, Shilpi Khetarpal, Breanna Pasko Jernigan
  Dermatologic Surgery.2025; 51(12S): S15.     CrossRef
• Nutritional Approaches to Enhance GLP-1 Analogue Therapy in Obesity: A Narrative Review
  Denise Deo Dias, Andrea Rodrigues Vasconcelos, Ana Carolina Remondi Souza, Caroline de Menezes, Isabella Sobral Teixeira e Silva, José João Name
  Obesities.2025; 5(4): 88.     CrossRef
• Einfluss von GLP-1-Analoga auf die Mikronährstoffversorgung
  Felix Kerlikowsky, Klaus Krämer, Manfred Eggersdorfer, Andreas Hahn
  Ernährung & Medizin.2025; 40(04): 167.     CrossRef
• Glucagon-like peptide-1 receptor agonists: What ophthalmologists need to know
  Suraj Bala, Kevin C. Allan, Nicole L. Decker, Nadia J. Abbass, Julia H. Joo, Alison Zhao, Katherine E. Talcott, Aleksandra V. Rachitskaya
  Survey of Ophthalmology.2025;[Epub]     CrossRef
• Diabetes and Osteoarthritis: Exploring the Interactions and Therapeutic Implications of Insulin, Metformin, and GLP-1-Based Interventions
  Iryna Halabitska, Liliia Babinets, Valentyn Oksenych, Oleksandr Kamyshnyi
  Biomedicines.2024; 12(8): 1630.     CrossRef
• The Effect of Tirzepatide on Body Composition in People with Overweight and Obesity: A Systematic Review of Randomized, Controlled Studies
  Vincenzo Rochira, Carla Greco, Stefano Boni, Francesco Costantino, Leonardo Dalla Valentina, Eleonora Zanni, Leila Itani, Marwan El Ghoch
  Diseases.2024; 12(9): 204.     CrossRef
• Glucagon-like peptide-1 receptor: mechanisms and advances in therapy
  Zhikai Zheng, Yao Zong, Yiyang Ma, Yucheng Tian, Yidan Pang, Changqing Zhang, Junjie Gao
  Signal Transduction and Targeted Therapy.2024;[Epub]     CrossRef
• Recent Advances and Therapeutic Benefits of Glucagon-Like Peptide-1 (GLP-1) Agonists in the Management of Type 2 Diabetes and Associated Metabolic Disorders
  John O Olukorode, Dolapo A Orimoloye, Nwachukwu O Nwachukwu, Chidera N Onwuzo, Praise O Oloyede, Temiloluwa Fayemi, Oluwatobi S Odunaike, Petra S Ayobami-Ojo, Nwachi Divine, Demilade J Alo, Chukwurah U Alex
  Cureus.2024;[Epub]     CrossRef
• Interactions between glucagon like peptide 1 (GLP-1) and estrogens regulates lipid metabolism
  Jorge F.A. Model, Rafaella S. Normann, Éverton L. Vogt, Maiza Von Dentz, Marjoriane de Amaral, Rui Xu, Tsvetan Bachvaroff, Poli Mara Spritzer, J. Sook Chung, Anapaula S. Vinagre
  Biochemical Pharmacology.2024; 230: 116623.     CrossRef
• Changes in 24-Hour Urine Chemistry in Patients with Nephrolithiasis during Weight Loss with Glucagon-Like Peptide 1–Based Therapies
  Karen Feghali, Xilong Li, Naim M. Maalouf
  Kidney360.2024; 5(11): 1706.     CrossRef
• Liuweizhiji Gegen-Sangshen beverage protects against alcoholic liver disease in mice through the gut microbiota mediated SCFAs/GPR43/GLP-1 pathway
  Mingyun Tang, Long Zhao, Fuchun Huang, Tiangang Wang, Xu Wu, Shanshan Chen, Juan Fu, Chaoli Jiang, Shulin Wei, Xuseng Zeng, Xiaoling Zhang, Xin Zhou, Mei Wei, Zhi Li, Guohui Xiao
  Frontiers in Nutrition.2024;[Epub]     CrossRef
• Spotlight on the Mechanism of Action of Semaglutide
  Ilias Papakonstantinou, Konstantinos Tsioufis, Vasiliki Katsi
  Current Issues in Molecular Biology.2024; 46(12): 14514.     CrossRef